About Me
R & D and commercialization management in sciences, healthcare, and technology.
Products and Services include:
ISO 13485, 15189, 17025, 50501
CFR 21, FDA QMS & GMP
FARM Act, STATES Act, IRS 280E Compliance, SWIFT alternative settlements, Blockchain/ Hempchain, Blockchain Smart Contracts, DAP, DAO, Dispensary License Financing, Cannabis Supply Chain Management (CSCM), Medicinal QMS, ISO 17025, Cannabis GMP, LDT, International Cannabis Clinical Trials, FDA equivalent packaging.
Medicinal and clinical applications: Inflammation, Rheumatoid Arthritis, Gastroenterology, Wound Care, Epilepsy, and others.
Clinical Research Management: Medical Communications, Scientific Communications, COM-B, CFIR.
HEOR, Market Access, Health Technology Assessments, Real World Evidence, Real World Data, Pharmacoeconomics, Implementation Sciences, Translational Research, Evidence-based Medicine.
Novel IVD and MDx, CDx development and commercialization, CLIA, CAP, COLA, microfluidics, biosensors, Point of Care, Near Patient Testing, LIS and Lab Informatics, Assays, Analyzers, OTC, Reference Lab, Specimen Collection Logistics, Precision Medicine. NGS, CLMA, AACC, IOP, POL.
Medical Sales and Marketing. Direct Detail Rep Management, Distribution, Export, Import, PBM, B2B Electronic Commerce Platforms (Amazon, Alibaba, etc), GPO contracting and engagement, Specialty and Reference Labs, CPT, CMS and Commercial Carrier engagement, Partnerships, Alliances, JV’s, Brand Development, Brand Equity, Social Marketing, 1:1 Marketing, Attribution. Account-Based Marketing, Mobile and Social Marketing (SMAC).
Healthcare Transformation: Patient-Centered Medical Homes, ACO, CIN, IDN, MSO, IPA, Retail Clinics, Telecare, Remote Patient Monitoring, Health Informatics, Population Heath, SDoH, Medical Tourism, Concierge and Direct Care, IOP’s, POL’s, Value-Based Care, FQHC, Telemedicine, Kiosk Care, Home Care, On-Site Clinics, Clinical Engineering, Health Economics, Market Access, Regulatory Affairs and Government Relations.
Products and Technologies/Emerging Innovations: Nitinol, Telemedicine, Home Based Diagnostics, Mobile Care, Digital Health, Wearables, Sensors, Printed Electronics, Smart Fabrics, BioPrinting, Stem Cells, Medical and Functional Foods, Genomics, Cognitive Sciences, Applied Behavioral Economics, Care Coordination, FHIR, API, Open Notes, Open Science, Technology Transfer, Licensing, Smart Plastics, 3D Printing, Precision and Personalized Medicine, Integrative Care, Nanotechnology, Apps, IoT, Clean Fuels, Smart Home, Smart City.
IPO Experience going public with IVD diagnostics company on American Stock Exchange in 1999.
Cannabis enterprise valuation, due diligence, origination with debt, equity, convertibles. Canadian markets coverage. Post-STATES Act Financial modeling and valuation.
Servsee less
City
New Orleans
Pages
There are no results that match your search. Please try again.
